We are live on ! Find out more
SO

STRS Ohio Portfolio holdings

AUM $25.2B
1-Year Est. Return 30.31%
This Fund
S&P 500
This Quarter Est. Return
+9.29%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$27.8B
AUM Growth
+$1.24B
Cap. Flow
-$912M
Cap. Flow %
-3.28%
Top 10 Hldgs %
21.54%
Holding
2,538
New
369
Increased
762
Reduced
883
Closed
318

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$74.4M
2
LIN icon
Linde
LIN
+$64.8M
3
UNH icon
UnitedHealth
UNH
+$58.1M
4
FHN icon
First Horizon
FHN
+$51.3M
5
PH icon
Parker-Hannifin
PH
+$46.3M

Sector Composition

Rank Sector Weight
1 Technology 23.71%
2 Financials 16.15%
3 Healthcare 11.99%
4 Consumer Discretionary 11.13%
5 Communication Services 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPCH icon
1401
Option Care Health
OPCH
$3.42B
$741K ﹤0.01%
33,900
+24,500
+261% +$472K
PHR icon
1402
Phreesia
PHR
$657M
$741K ﹤0.01%
12,100
CARE icon
1403
Carter Bankshares
CARE
$757M
$740K ﹤0.01%
59,200
+3,600
+6% +$50.3K
BPMC
1404
DELISTED
Blueprint Medicines
BPMC
$738K ﹤0.01%
8,400
+800
+11% +$73.3K
GSBC icon
1405
Great Southern Bancorp
GSBC
$863M
$738K ﹤0.01%
13,700
+1,300
+10% +$72.9K
NARI
1406
DELISTED
Inari Medical, Inc. Common Stock
NARI
$736K ﹤0.01%
+7,900
New +$766K
BFS
1407
Saul Centers
BFS
$884M
$735K ﹤0.01%
16,191
-837
-5% -$36.3K
LBC
1408
DELISTED
Luther Burbank Corporation Common Stock
LBC
$734K ﹤0.01%
61,900
-2,000
-3% -$23.6K
CTMX icon
1409
CytomX Therapeutics
CTMX
$708M
$733K ﹤0.01%
115,800
+26,900
+30% +$209K
AVAV icon
1410
AeroVironment
AVAV
$7.81B
$731K ﹤0.01%
7,300
-4,000
-35% -$440K
MOG.A icon
1411
Moog Inc Class A
MOG.A
$13.2B
$731K ﹤0.01%
8,700
+800
+10% +$69.2K
WTTR icon
1412
Select Water Solutions
WTTR
$2.34B
$730K ﹤0.01%
120,900
-2,300
-2% -$13.3K
PFBI
1413
DELISTED
Premier Financial Bancorp
PFBI
$729K ﹤0.01%
43,300
+4,100
+10% +$75.9K
DSGR icon
1414
Distribution Solutions Group
DSGR
$1.6B
$727K ﹤0.01%
27,200
-400
-1% -$11K
BVS icon
1415
Bioventus
BVS
$843M
$726K ﹤0.01%
41,300
+39,500
+2,194% +$637K
CLFD icon
1416
Clearfield
CLFD
$436M
$726K ﹤0.01%
19,400
-4,600
-19% -$163K
PBYI icon
1417
Puma Biotechnology
PBYI
$407M
$720K ﹤0.01%
78,500
+15,400
+24% +$156K
CAF
1418
Morgan Stanley China A Share Fund
CAF
$337M
$719K ﹤0.01%
31,442
CIO
1419
DELISTED
City Office REIT
CIO
$719K ﹤0.01%
57,885
-3,908
-6% -$45.3K
ABMD
1420
DELISTED
Abiomed Inc
ABMD
$719K ﹤0.01%
2,305
-3,569
-61% -$1.09M
RYZ
1421
Ryerson Holding Corp
RYZ
$1.59B
$718K ﹤0.01%
49,200
+4,600
+10% +$72.7K
HOME
1422
DELISTED
At Home Group Inc.
HOME
$718K ﹤0.01%
19,500
+3,300
+20% +$112K
BH icon
1423
Biglari Holdings Class B
BH
$1.17B
$717K ﹤0.01%
4,500
+400
+10% +$61.6K
CNNE icon
1424
Cannae Holdings
CNNE
$650M
$715K ﹤0.01%
21,100
-17,000
-45% -$634K
EQC
1425
DELISTED
Equity Commonwealth
EQC
$715K ﹤0.01%
+27,300
New +$760K

Similar funds

STRS Ohio's Q2 2021 Portfolio in Review

As of Q2 2021, STRS Ohio held 2,538 positions worth $27.8B, up 4.7% from $26.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

STRS Ohio withdrew a net $912M in Q2 2021, closing 318 positions and reducing 883 holdings. Its most notable exit was Linde, an estimated $64.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, STRS Ohio opened a new position in Cogent Communications worth $6.83M.

  • STRS Ohio's largest Q2 2021 buy was Cogent Communications: 88,900 shares worth $6.83M.
  • STRS Ohio added most to Snap in Q2 2021, an estimated $34.6M increase.
  • STRS Ohio's biggest Q2 2021 reduction was Apple, cutting an estimated $74.4M.
  • STRS Ohio fully exited Linde in Q2 2021, selling an estimated $64.8M.
  • STRS Ohio's ten largest holdings make up 22% of its $27.8B portfolio in Q2 2021.
  • STRS Ohio opened 369 new positions and closed 318 in Q2 2021.
  • STRS Ohio's portfolio value rose 4.7% quarter-over-quarter to $27.8B.

Based on STRS Ohio's 13F filing for Q2 2021, filed 26 Jul 2021.